SCHEMBL10011030

SCHEMBL10011030

C#CCOC(=O)CCCC(=O)OCC

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.58
CYP1A2 P05177 1/20 0.53
GSTP1 P09211 1/20 0.51
TSHR P16473 2/20 0.47
NR1I2 O75469 1/20 0.43
PGR P06401 1/20 0.43
ADORA3 P0DMS8 1/20 0.43
PTGS2 P35354 1/20 0.43
PDE4D Q08499 1/20 0.43
GAA P10253 2/20 0.43
MGAM O43451 1/20 0.43
SI P14410 1/20 0.43
MGAM2 Q2M2H8 1/20 0.43
RAB9A P51151 1/20 0.42
ALDH1A1 P00352 2/20 0.41
POLB P06746 1/20 0.41
CYP3A4 P08684 1/20 0.41
ALOX15 P16050 1/20 0.41
HSD17B10 Q99714 1/20 0.41
TDP1 Q9NUW8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10012032 0.96 GSTP1 (0.56) L3MBTL1CYP1A2GSTP1TSHRNR1I2
SCHEMBL10011826 0.94 L3MBTL1 (0.56) L3MBTL1CYP1A2GSTP1TSHRNR1I2
SCHEMBL10011388 0.92 L3MBTL1 (0.49) L3MBTL1CYP1A2GSTP1TSHRNR1I2
SCHEMBL10011454 0.89 GSTP1 (0.59) L3MBTL1CYP1A2GSTP1TSHRALDH1A1
SCHEMBL5805525 0.86 L3MBTL1 (0.64) L3MBTL1CYP1A2GSTP1TSHRALDH1A1
SCHEMBL1482992 0.85 GSTP1 (0.65) L3MBTL1CYP1A2GSTP1TSHRALDH1A1
SCHEMBL27924493 0.85 L3MBTL1 (0.55) L3MBTL1CYP1A2GSTP1TSHRALDH1A1
SCHEMBL10010056 0.85 L3MBTL1 (0.59) L3MBTL1CYP1A2GSTP1TSHRALDH1A1
SCHEMBL27943833 0.84 L3MBTL1 (0.54) L3MBTL1CYP1A2GSTP1TSHRALDH1A1
SCHEMBL10009670 0.84 TSHR (0.60) L3MBTL1GSTP1TSHRALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9130244-B2 Nonaqueous electrolyte solution and electrochemical element using same UBE INDUSTRIES, LTD. (JP) 2015-09-08 US disclosed
EP-2908376-A1 NONAQUEOUS ELECTROLYTE SOLUTION AND ELECTROCHEMICAL ELEMENT USING SAME Ube Industries, Ltd. (JP) 2015-08-19 EP disclosed
EP-2479831-A1 NONAQUEOUS ELECTROLYTE SOLUTION AND ELECTROCHEMICAL ELEMENT USING SAME Ube Industries, Ltd. (JP) 2012-07-25 EP disclosed
US-20120171581-A1 NONAQUEOUS ELECTROLYTE SOLUTION AND ELECTROCHEMICAL ELEMENT USING SAME UBE INDUSTRIES, LTD. (JP) 2012-07-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120171581-A1 NONAQUEOUS ELECTROLYTE SOLUTION AND ELECTROCHEMICAL ELEMENT USING SAME SLC8A1, OR10J3, SLC8B1 L3MBTL1 3802/4885CYP1A2 3415/4885GSTP1 3928/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.